Nicolas Jacques Francois Dreyfus,Peter James Lindsay-Scott,Richard Edmund Rathmell
申请号:
US15983269
公开号:
US10377750B2
申请日:
2018.05.18
申请国别(地区):
US
年份:
2019
代理人:
摘要:
The present invention provides a compound of Formula I:or a pharmaceutically acceptable salt thereof, and the use of compounds of Formula I for treatment of neurodegenerative diseases and disorders, such as Alzheimer's disease.